Inovio Pharmaceuticals
INO
INO
127 hedge funds and large institutions have $171M invested in Inovio Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.78% more ownership
Funds ownership: 3.11% → 3.89% (+0.78%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less call options, than puts
Call options by funds: $267K | Put options by funds: $383K
Holders
127
Holding in Top 10
1
Calls
$267K
Puts
$383K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$11.9M | |
| 3 | +$3.89M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.05M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.9M |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$856K | |
| 3 | -$684K | |
| 4 |
Morgan Stanley
New York
|
-$418K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$406K |